SUMMARY:

  • The states struggling the most with covid-19 infections also have the least healthy populations.
  • About two out of five American adults are obese, according to the CDC. Mostly because they don’t understand how what they eat effects their health.
  • Only 23% of people get enough exercise and only one in ten eats enough fruit and vegetables, says the CDC
  • Less than half of Americans are proficient readers, and only 12% are considered by the country’s health department to be “health-literate”. 
  • Over one-third struggle with basic health tasks, such as following prescription-drug directions.

SUMMARY:

  • People are going online more and more to sarch for health information after seeing a DTC pharma TV spot.
  • Pharma websites are not consdiered a top resource for infromation on new products.
  • Cost is not that big of an issue for people who have health insurance.
  • It’s more about weighing the benefit against the potential side effects.
  • TV spots are the number one way people learn about new pharma products.

SUMMARY:

  • According to the NEJM “in participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight”.
  • In the clinical study, participants were enrolled in an “intensive” behavioral study with 8 weeks low-calorie diet.
  • Yet the media has led with “diabetes drug leads to major weight loss”.
  • Will doctors inform patients?

SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post, says “the worst thing for people with Alzheimer’s would be to put out a product that doesn’t work.” For Biogen, the stakes are high as approval is likely to earn tens of millions, of to billions, in profits but is hope a reason to approve a drug over science?